A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Clinical trial NCT05934513 · RECRUITING
Trial details
- NCT number
- NCT05934513
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-06
- Primary completion
- 2025-12-30
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.